Kau patent opposition analysis

The comprehensive analysis of Kau opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Kau

Patent NumberTitleApplicantOpposition DateOpposition Company
Methods Of Treating Conditions Related To The S1P1 ReceptorARENA PHARMACEUTICALSJul 16, 2025TEVA PHARMACEUTICALS
Methods Of Treating Conditions Related To The S1P1 ReceptorARENA PHARMACEUTICALSMay 7, 2025TEVA PHARMACEUTICALS
Compounds And Methods For Treatment Of Inflammatory Bowel Disease With Extra-Intestinal ManifestationsARENA PHARMACEUTICALSFeb 1, 2025TEVA PHARMACEUTICALS
Methods For Preventing Cardiovascular Events Through Proprotein Convertase Subtilisin Kexin 9 (Pcsk9) Protein ReductionNOVARTISJan 17, 2025TEVA PHARMACEUTICALS
Polymorphic Forms Of Rad1901-2HclRADIUS PHARMACEUTICALSJan 10, 2025TEVA PHARMACEUTICALS
Feed Screw-Type Machine For Feeding A Processing Screw-Type Machine, And Related MethodCOPERIONJan 2, 2025KRAUSSMAFFEI EXTRUSION
Device For Applying Vibrations To Passenger CarsBEP EUROPEDec 20, 2024DURR ASSEMBLY PRODUCTS
Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIMOct 16, 2024TEVA PHARMACEUTICALS
Pharmaceutical Formulations Of Bruton'S Tyrosine Kinase InhibtorPHARMACYCLICSAug 21, 2024TEVA PHARMACEUTICALS
Methods Of Treating Or Preventing Spinal Muscular AtrophyBIOGEN MAAug 21, 2024TEVA PHARMACEUTICALS